Star Imaging and Path Lab Ltd IPO

The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India.

Open Demat Account

50years

Star Imaging and Path Lab Ltd IPO Details

Details

Total Shares OfferedOffer to PublicRetail Max (Shares)Pre Issue Promoters HoldingExchangeIssue size
₹ 48.92 L₹ 9.72 LTBA₹ 158.5 LBSE₹ 69.47 Cr
IPO Open DateClose DateLot SizeMin InvestmentIssue TypeListing Date
08 Aug, 2512 Aug, 252000 ₹ 2,70,000 Book Building - SME18 Aug, 25

Star Imaging and Path Lab Ltd IPO Dates

  • 08 Aug 2025

    Opening date

  • 12 Aug 2025

    Closing date

  • 13 Aug 2025

    Basis of
    Allotment

  • 13 Aug 2025

    Initiation of
    Refunds

  • 14 Aug 2025

    Credit of
    Shares

  • 18 Aug 2025

    Listing date

Details

SectorType
SectorHealthcare
Sub SectorNA
Issue TypeBook Building - SME

Subscription Status

*Values are in Lakhs

Investor TypeSubscription TimesShares Offered*Shares Bid*
QIB0x00
NII0x00
Retail0x00
Employee0x00
Total0x48920000

Subscription Status

Investor Type

QIB

NII

Retail

Employee

Total

*Values are in Lakhs

Star Imaging and Path Lab Ltd Financial Status

Income Statement

Balance Sheet

Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations21.254.2212.91
EBITDA26.497.5616.42
PAT12.340.576.30
Total Assets53.0726.1131.51
Share Capital1.501.501.50
Total Borrowings15.9316.4818.04
Operating Activities (Net Cash)17.583.919.81
Investing Activities (Net Cash)0.010.010.01
Financing Activities (Net Cash)15.9316.4818.04
Net Cashflow15.442.188.97

Particulars (in Rs. Crores)

Revenue from operations

EBITDA

PAT

Total Assets

Share Capital

Total Borrowings

Operating Activities (Net Cash)

Investing Activities (Net Cash)

Financing Activities (Net Cash)

Net Cashflow

About Star Imaging and Path Lab Ltd

Our Company was originally incorporated as a private limited company under the Companies Act, 1956 in the name and style of Star Imaging & Path Lab Private Limited bearing Corporate Identification Number U85110DL2004PTC126679 dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, our Company was converted into a Public Limited Company vide Special Resolution passed by the Shareholders at the Extra-Ordinary General Meeting, held on April 12, 2024, and consequently the name of our Company was changed from Star Imaging and Path Lab Private Limited to Star Imaging and Path Lab Limited vide a fresh certificate of incorporation dated September 17, 2024 issued by the Registrar of Companies, Central Processing Centre bearing CIN U85110DL2004PLC126679.

Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000-19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World Economic Outlook (WEO), primarily on account of an upward revision in the United States offsetting downward revisions in other major economies. Global headline inflation is expected to decline to 4.2 percent in 2025 and to 3.5 percent in 2026, converging back to target earlier in advanced economies than in emerging market and developing economies. Medium-term risks to the baseline are tilted to the downside, while the near-term outlook is characterized by divergent risks. Upside risks could lift already-robust growth in the United States in the short run, whereas risks in other countries are on the downside amid elevated policy uncertainty. Policy-generated disruptions to the ongoing disinflation process could interrupt the pivot to easing monetary policy, with implications for fiscal sustainability and financial stability. Managing these risks requires a keen policy focus on balancing trade-offs between inflation and real activity, rebuilding buffers, and lifting medium-term growth prospects through stepped-up structural reforms as well as stronger multilateral rules and cooperation. Forces Shaping the Outlook: The global economy is holding steady, although the degree of grip varies widely across countries. Global GDP growth in the third quarter of 2024 was 0.1 percentage point below that predicted in the October 2024 WEO, after disappointing data releases in some Asian and European economies. Growth in China, at 4.7 percent in year-over-year terms, was below expectations. Faster-than-expected net export growth only partly offset a faster-than-expected slowdown in consumption amid delayed stabilization in the property market and persistently low consumer confidence. Growth in India also slowed more than expected, led by a sharper-than-expected deceleration in industrial activity. Growth continued to be subdued in the euro area (with Germany's performance lagging that of other euro area countries), largely reflecting continued weakness in manufacturing and goods exports even as consumption picked up in line with the recovery in real incomes. In Japan, output contracted mildly owing to temporary supply disruptions. By contrast, momentum in the United States remained robust, with the economy expanding at a rate of 2.7 percent in year-over-year terms in the third quarter, powered by strong consumption. Global disinflation continues, but there are signs that progress is stalling in some countries and that elevated inflation is persistent in a few cases. The global median of sequential core inflation has been just slightly above 2 percent for the past few months. Nominal wage growth is showing signs of moderation, alongside indications of continuing normalization in labor markets. Although core goods price inflation has fallen back to or below trend, services price inflation is still running above pre-COVID-19 averages in many economies, most notably the United States and the euro area. Pockets of elevated inflation, reflecting a range of idiosyncratic factors, also persist in some emerging market and developing economies in Europe and Latin America. Where inflation is proving moresticky, central banks are moving more cautiously in the easing cycle while keeping a close eye on activity and labor market indicators as well as exchange rate movements. A few central banks are raising rates, marking a point of divergence in monetary policy. Global financial conditions remain largely accommodative, again with some differentiation across jurisdictions (see Box 1). Equities in advanced economies have rallied on expectations of more business friendly policies in the United States. In emerging market and developing economies, equity valuations have been more subdued, and a broad-based strengthening of the US dollar, driven primarily by expectations of new tariffs and higher interest rates in the United States, has kept financial conditions tighter. Economic policy uncertainty has increased sharply, especially on the trade and fiscal fronts, with some differentiation across countries (Figure 1). Expectations of policy shifts under newly elected governments in 2024 have shaped financial market pricing in recent months. Bouts of political instability in some Asian and European countries have rattled markets and injected additional uncertainty regarding stalled progress on fiscal and structural policies. Geopolitical tensions, including those in the Middle East, and global trade frictions remain elevated.

The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India.

Star Imaging and Path Lab Ltd IPO Key Points

Strengths

  • Integrated diagnostics provider with one-stop solution offering pathology and radiology services.
  • Established presence and proven track record.
  • Dedicated management team with significant industry experience.

Risk

  • Our Company, Promoter and Directors are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition.
  • There have been instances in the past where we have not made regulatory filing of Consolidated Financials of our Company with RoC.
  • Our Company has reported certain negative cash flows from its operating activity, investing activity and financing activity, details of which are given below.

Strategy

  • Continue to expand presence across India.
  • Expand our offering of diagnostic services with a focus on specialized diagnostics.
  • Integrated diagnostics provider with one-stop solution offering pathology and radiology services.
  • Established presence and proven track record.
  • Dedicated management team with significant industry experience.

How To Apply for Star Imaging and Path Lab Ltd IPO Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

Get your FAQs right

Star Imaging and Path Lab Ltd's IPO offers shares for up to ₹ 0 L It begins on Aug 8, 2025 and ends on Aug 12, 2025.

The price of Star Imaging and Path Lab Ltd IPO ranges between ₹135 to ₹142 per share.

The Star Imaging and Path Lab Ltd IPO opens on Aug 8, 2025 and closes on Aug 12, 2025.

The allotment for the Star Imaging and Path Lab Ltd IPO will be finalised on Aug 13, 2025. The shares will be listed on BSE and NSE on Aug 18, 2025.

The minimum lot size for Star Imaging and Path Lab Ltd IPO is 2000 shares, priced between ₹135 to ₹142 per share.

The GMP (Grey Market Premium) of Star Imaging and Path Lab Ltd IPO fluctuates based on market demand and sentiment.

To check the allotment status of Star Imaging and Path Lab Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

The Star Imaging and Path Lab Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Aug 8, 2025, and closes on Aug 12, 2025. The allotment is finalised on Aug 13, 2025.

To apply for the Star Imaging and Path Lab Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.